Understanding the role of video direct observed therapy for patients on an oral short-course regimen for multi-drug resistant tuberculosis: findings from a qualitative study in Eswatini.
Eswatini
MDR-TB
Oral short course treatment
Qualitative
vDOT
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
15 Aug 2024
15 Aug 2024
Historique:
received:
09
04
2024
accepted:
09
08
2024
medline:
16
8
2024
pubmed:
16
8
2024
entrez:
15
8
2024
Statut:
epublish
Résumé
Improving treatment success rates among multi drug-resistant tuberculosis (MDR-TB) patients is critical to reducing its incidence and mortality, but adherence poses an important challenge. Video-based direct observed therapy (vDOT) may provide adherence benefits, while addressing the time and cost burden associated with community treatment supporter (CTS)-DOT. This study explored experiences of patients, family members and healthcare workers with different DOT modalities for adherence support in Eswatini. Between April 2021 and May 2022, thirteen men and five women with MDR-TB, ten healthcare workers, and nine caregivers were purposively sampled to include a range of characteristics and experiences with DOT modalities. Data were generated through individual in-depth interviews and a smartphone messaging application (WhatsApp). Data coding was undertaken iteratively, and thematic analysis undertaken, supported by Nvivo. Four themes emerged that reflected participants' experiences with different DOT modalities, including stigma, efficiency, perceived risks of TB acquisition, and patient autonomy. vDOT was appreciated by patients for providing them with privacy and shielding them from stigmatisation associated with being seen in TB clinics or with community treatment supporters. vDOT was also seen as more efficient than CTS-DOT. Health workers acknowledged that it saved time, allowing them to attend to more patients, while many patients found vDOT more convenient and less expensive by removing the need to travel for in-person consultations. Health workers also appreciated vDOT because it reduced risks of TB acquisition by minimising exposure through virtual patient monitoring. Although many patients appreciated greater autonomy in managing their illness through vDOT, others preferred human contact or struggled with making video recordings. Most family members appreciated vDOT, although some resented feeling removed from the process of supporting loved ones. vDOT was generally appreciated by MDR-TB patients, their family members and health workers as it addressed barriers to adherence which could contribute to improved treatment completion rates and reduced workplace exposure. However, patients should be offered an alternative to vDOT such as CTS-DOT if this modality does not suit their circumstances or preferences.
Sections du résumé
BACKGROUND
BACKGROUND
Improving treatment success rates among multi drug-resistant tuberculosis (MDR-TB) patients is critical to reducing its incidence and mortality, but adherence poses an important challenge. Video-based direct observed therapy (vDOT) may provide adherence benefits, while addressing the time and cost burden associated with community treatment supporter (CTS)-DOT. This study explored experiences of patients, family members and healthcare workers with different DOT modalities for adherence support in Eswatini.
METHODS
METHODS
Between April 2021 and May 2022, thirteen men and five women with MDR-TB, ten healthcare workers, and nine caregivers were purposively sampled to include a range of characteristics and experiences with DOT modalities. Data were generated through individual in-depth interviews and a smartphone messaging application (WhatsApp). Data coding was undertaken iteratively, and thematic analysis undertaken, supported by Nvivo.
RESULTS
RESULTS
Four themes emerged that reflected participants' experiences with different DOT modalities, including stigma, efficiency, perceived risks of TB acquisition, and patient autonomy. vDOT was appreciated by patients for providing them with privacy and shielding them from stigmatisation associated with being seen in TB clinics or with community treatment supporters. vDOT was also seen as more efficient than CTS-DOT. Health workers acknowledged that it saved time, allowing them to attend to more patients, while many patients found vDOT more convenient and less expensive by removing the need to travel for in-person consultations. Health workers also appreciated vDOT because it reduced risks of TB acquisition by minimising exposure through virtual patient monitoring. Although many patients appreciated greater autonomy in managing their illness through vDOT, others preferred human contact or struggled with making video recordings. Most family members appreciated vDOT, although some resented feeling removed from the process of supporting loved ones.
CONCLUSIONS
CONCLUSIONS
vDOT was generally appreciated by MDR-TB patients, their family members and health workers as it addressed barriers to adherence which could contribute to improved treatment completion rates and reduced workplace exposure. However, patients should be offered an alternative to vDOT such as CTS-DOT if this modality does not suit their circumstances or preferences.
Identifiants
pubmed: 39148081
doi: 10.1186/s12879-024-09744-9
pii: 10.1186/s12879-024-09744-9
doi:
Substances chimiques
Antitubercular Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
829Informations de copyright
© 2024. The Author(s).
Références
WHO. Global Tuberculosis Report 2022. Accessed: Mar. 02, 2023. [Online]. Available: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022
WHO. Global tuberculosis report: Country, regional and global profiles. Accessed: Mar. 14, 2024. [Online]. Available: https://www.who.int/teams/global-tuberculosis-programme/data
Ministry of Health, Eswatini. National Tuberculosis Programme. Accessed: Mar. 06, 2023. [Online]. Available: https://www.gov.sz/index.php/departments-sp-654042511?id=471
Kerschberger B, et al. Successful expansion of community-based drug-resistant TB care in rural Eswatini – a retrospective cohort study. Trop Med Int Health. 2019;24(10):1243–58. https://doi.org/10.1111/tmi.13299 .
doi: 10.1111/tmi.13299
pubmed: 31390108
pmcid: 6851784
World Health Organization, Guidelines for treatment of drug-susceptible tuberculosis and patient care. 2017 update. Geneva: World Health Organization, 2017. Accessed: Mar. 19, 2024. [Online]. Available: https://iris.who.int/handle/10665/255052
Karumbi J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. May 2015. https://doi.org/10.1002/14651858.CD003343.pub4 .
Mohr E, et al. DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting. PLoS ONE. May 2017;12(5):e0178054. https://doi.org/10.1371/journal.pone.0178054 .
de Queiroz EM, De-La-Torre-Ugarte-Guanilo MC, Ferreira KR, Bertolozzi MR. Tuberculosis: limitations and strengths of directly observed treatment short-course. Rev Lat Am Enfermagem. 2012;20(2):369–77. https://doi.org/10.1590/s0104-11692012000200021 .
doi: 10.1590/s0104-11692012000200021
pubmed: 22699739
Ormel HL, van der Schoot GGF, Westerink N-DL, Sluiter WJ, Gietema JA, Walenkamp AME. Self-monitoring physical activity with a smartphone application in cancer patients: a randomized feasibility study (SMART-trial). Support Care Cancer. 2018;26(11):3915–23. https://doi.org/10.1007/s00520-018-4263-5 .
doi: 10.1007/s00520-018-4263-5
pubmed: 29785635
pmcid: 6182373
Mayer DK, et al. SurvivorCHESS to increase physical activity in colon cancer survivors: can we get them moving? J Cancer Surviv Res Pract. Feb. 2018;12(1):82–94. https://doi.org/10.1007/s11764-017-0647-7 .
Wannheden C, Stenfors T, Stenling A, von Schwarz U. Satisfied or Frustrated? A Qualitative Analysis of Need Satisfying and Need Frustrating Experiences of Engaging With Digital Health Technology in Chronic Care, Front. Public Health, vol. 8, 2021, Accessed: Mar. 01, 2022. [Online]. Available: https://www.frontiersin.org/article/ https://doi.org/10.3389/fpubh.2020.623773
WHO. consolidated guidelines on drug-resistant tuberculosis treatment. in WHO Guidelines Approved by the Guidelines Review Committee. Geneva: World Health Organization, 2019. Accessed: Mar. 28, 2023. [Online]. Available: http://www.ncbi.nlm.nih.gov/books/NBK539517/
WHO. WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-resistant tuberculosis treatment. Accessed: Mar. 14, 2024. [Online]. Available: https://www.who.int/publications-detail-redirect/9789240007048
Scheunemann A, et al. The lived experiences of tuberculosis survivors during the COVID-19 pandemic and government lockdown in South Africa: a qualitative analysis. BMC Public Health. Sep. 2023;23(1):1729. https://doi.org/10.1186/s12889-023-16657-w .
COVID-19 pandemic slows progress against tuberculosis, WHO | Regional Office for Africa. Accessed: Sep. 06, 2023. [Online]. Available: https://www.afro.who.int/news/covid-19-pandemic-slows-progress-against-tuberculosis
Vanleeuw L, Zembe-Mkabile W, Atkins S. Falling through the cracks: increased vulnerability and limited social assistance for TB patients and their households during COVID-19 in Cape Town, South Africa. PLOS Glob Public Health. Jul. 2022;2(7):e0000708. https://doi.org/10.1371/journal.pgph.0000708 .
Kerschberger B, et al. The introduction of video-enabled directly observed therapy (video-DOT) for patients with drug-resistant TB disease in Eswatini amid the COVID-19 pandemic – a retrospective cohort study. BMC Health Serv Res. Jun. 2024;24(1):699. https://doi.org/10.1186/s12913-024-11151-4 .
Ministry of Health, Eswatini. Swaziland HIV Incidence Measurement Survey (SHIMS)3, PHIA Project. Accessed: May 13, 2023. [Online]. Available: https://phia.icap.columbia.edu/eswatini-summary-sheet-2021/
SureAdhere. Mobile Technology Inc, SureAdhere. Accessed: Jul. 26, 2024. [Online]. Available: https://www.sureadhere.com
Glaser BG. The Future of Grounded Theory, Qual. Health Res, vol. 9, no. 6, pp. 836–845, Nov. 1999, https://doi.org/10.1177/104973299129122199
Merriam SB, Tisdell EJ. Qualitative research: a guide to design and implementation. Wiley; 2015.
Bradley EH, Curry LA, Devers KJ, Qualitative Data Analysis for Health Services Research. Aug., : Developing Taxonomy, Themes, and Theory, Health Serv. Res, vol. 42, no. 4, pp. 1758–1772, 2007, https://doi.org/10.1111/j.1475-6773.2006.00684.x
Kara GC, Yalcin BM. Comparison of In-Person vs. Video Directly Observed Therapy (VDOT) on Stigma Levels in Tuberculosis Patients, J. Am. Board Fam. Med. JABFM, p. jabfm.2022.AP.210514, Aug. 2022, https://doi.org/10.3122/jabfm.2022.AP.210514
Patient adherence. to tuberculosis treatment: a systematic review of qualitative research - PubMed. Accessed: Mar. 14, 2024. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/17676945/
Garfein RS et al. Oct., Tuberculosis Treatment Monitoring by Video Directly Observed Therapy in 5 Health Districts, California, USA, Emerg. Infect. Dis, vol. 24, no. 10, pp. 1806–1815, 2018, https://doi.org/10.3201/eid2410.180459
Zúñiga ML, et al. A qualitative study exploring stakeholder perceptions of video directly observed therapy for monitoring tuberculosis treatment in the US-Mexico Border Region. J Mob Technol Med. Jul. 2016;5(2):12–23.
Sekandi JN, et al. Stakeholders’ perceptions of benefits of and barriers to using video-observed treatment for monitoring patients with tuberculosis in Uganda: exploratory qualitative study. JMIR MHealth UHealth. Oct. 2021;9(10):e27131. https://doi.org/10.2196/27131 .
Rosu L, et al. Cost of digital technologies and family-observed DOT for a shorter MDR-TB regimen: a modelling study in Ethiopia, India and Uganda. BMC Health Serv Res. Nov. 2023;23(1):1275. https://doi.org/10.1186/s12913-023-10295-z .
Sekandi JN, et al. Acceptability, usefulness, and ease of Use of an enhanced video directly observed treatment system for supporting patients with tuberculosis in Kampala, Uganda: explanatory qualitative study. JMIR Form Res. Nov. 2023;7:e46203. https://doi.org/10.2196/46203 .
Rabinovich L, Molton JS, Ooi WT, Paton NI, Batra S, Yoong J. Perceptions and acceptability of Digital interventions among Tuberculosis patients in Cambodia: qualitative study of video-based directly observed therapy. J Med Internet Res. Jul. 2020;22(7):e16856. https://doi.org/10.2196/16856 .
Burtscher D et al. Jun., ‘She is like my mother’: Community-based care of drug-resistant tuberculosis in rural Eswatini, Glob. Public Health, vol. 16, no. 6, pp. 911–923, 2021, https://doi.org/10.1080/17441692.2020.1808039
McMillan SS, et al. Patient-centered approaches to health care: a systematic review of randomized controlled trials. Med Care Res Rev MCRR. Dec. 2013;70(6):567–96. https://doi.org/10.1177/1077558713496318 .
Harries AD, Maher D, Nunn P. Practical and affordable measures for the protection of health care workers from tuberculosis in low-income countries. Bull World Health Organ. 1997;75(5):477–89.
pubmed: 9447782
pmcid: 2487014
Grobler L, et al. The epidemiology of tuberculosis in health care workers in South Africa: a systematic review. BMC Health Serv Res. Aug. 2016;16(1):416. https://doi.org/10.1186/s12913-016-1601-5 .
Keedle H, Schmied V, Burns E, Dahlen H. The design, Development, and evaluation of a qualitative data Collection application for pregnant women. J Nurs Scholarsh off Publ Sigma Theta Tau Int Honor Soc Nurs. Jan. 2018;50(1):47–55. https://doi.org/10.1111/jnu.12344 .